SGC-CBP30

Product Name: SGC-CBP30
CAS No.: 1613695-14-9
Chemical Name: SGC-CBP30
Synonyms: CS-993;SGCBP30;CS-1923;SGC-CBP30;SGCBP30;SGCCBP 30;SGCCBP30;SGC CBP30;SGC-CBP30 USP/EP/BP;(S)-4-(1-(2-(3-Chloro-4-methoxyphenethyl)-5-(3,5-dimethylisoxazol-4-yl)-1H-benzo[d]imidazol-1-;2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-4-isoxazolyl)-1-[(2S)-2-(4-morpholinyl)propyl]-1H-benzimidazole;1H-Benzimidazole, 2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-4-isoxazolyl)-1-[(2S)-2-(4-morpholinyl)propyl]-
CBNumber: CB52670792
Molecular Formula: C28H33ClN4O3
Formula Weight: 509.04
MOL File: 1613695-14-9.mol

More

Less

SGC-CBP30 Property

Boiling point:: 678.0±55.0 °C(Predicted)
Density: 1.28±0.1 g/cm3(Predicted)
storage temp.: 2-8°C
solubility: ≥20.05 mg/mL in DMSO; ≥25.7 mg/mL in EtOH with ultrasonic; ≥4.67 mg/mL in H2O with ultrasonic
form: powder
pka: 6.98±0.10(Predicted)
color: white to beige

More

Less

Safety

WGK Germany: 3

More

Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Warning

Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More

Less

N-Bromosuccinimide Price

Sigma-Aldrich

Product number: SML1133
Product name: SGC-CBP30
Purity: ≥98% (HPLC)
Packaging: 5mg
Price: $160
Updated: 2024/03/01

Sigma-Aldrich

Product number: SML1133
Product name: SGC-CBP30
Purity: ≥98% (HPLC)
Packaging: 25mg
Price: $634
Updated: 2024/03/01

Cayman Chemical

Product number: 14469
Product name: SGC-CBP30
Purity: ≥98%
Packaging: 5mg
Price: $110
Updated: 2024/03/01

Cayman Chemical

Product number: 14469
Product name: SGC-CBP30
Purity: ≥98%
Packaging: 10mg
Price: $208
Updated: 2024/03/01

Cayman Chemical

Product number: 14469
Product name: SGC-CBP30
Purity: ≥98%
Packaging: 50mg
Price: $812
Updated: 2024/03/01

More

Less

SGC-CBP30 Chemical Properties,Usage,Production

Description

SGC-CBP30 is a potent CBP/p300 bromodomain (BRD) inhibitor. SGC-CBP30 shows Kd values are 21 and 32 nM for CBP and p300 BRDs respectively. SGC-CBP30 also exhibits 40-fold and 250-fold selectivity for CBP over the first BRD of BRD4 (BRD4(1)) and BRD4(2) respectively. SGC-CBP30 accelerates FRAP recovery in cells at a concentration of 1 ?M.

Uses

SGC-CBP30 is a potent CREBBP/EP300 inhibitor.

Biochem/physiol Actions

SGC-CBP30 is a selective inhibitor of the bromodomain-containing transcription factors CREBBP (CBP) and EP300 (IC50 = 0.021 and 0.038 μM, respectively). SGC-CBP30 has little activity against other bromodomains at concentrations up to 1 mM. For full characterization details, please visit the SGC-CBP30 probe summary on the Structural Genomics Consortium (SGC) website.To learn about other SGC chemical probes for epigenetic targets, visit sigma.com/sgc

target

CREBBP

storage

Store at +4°C

SGC-CBP30 Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

SGC-CBP30 Suppliers

China 74 India 2 United Kingdom 1 United States 15 Global 92

Tocris Bioscience

Tel: --
Fax: --
Email: customerservice@tocris.co.uk
Country: United Kingdom
ProdList: 5726
Advantage: 77

More

Less

View Lastest Price from SGC-CBP30 manufacturers

Career Henan Chemica Co

Product: SGC-CBP30 1613695-14-9
Price: US $9.80-8.00/KG
Min. Order: 1KG
Purity: 95%~99.99%
Supply Ability: 10 MT/ Month
Release date: 2020-10-28

1613695-14-9, SGC-CBP30Related Search:

I-BET151 (GSK1210151A) Tazemetostat (EPZ-6438) UNC-1215 (+)-JQ1 BroMosporine UNC 1999

SGC-CBP30

2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole

2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-4-isoxazolyl)-1-[(2S)-2-(4-morpholinyl)propyl]-1H-benzimidazole SGC-CBP30

2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(S)-2-(morpholin-4-yl)propyl]-1H-benzimidazole

2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-4-isoxazolyl)-1-[(2S)-2-(4-morpholinyl)propyl]-1H-benzimidazole

(S)-4-(1-(2-(3-Chloro-4-methoxyphenethyl)-5-(3,5-dimethylisoxazol-4-yl)-1H-benzo[d]imidazol-1-

CS-1923

SGCBP30

SGCBP30;SGCCBP 30

CS-993

SGCCBP30;SGC CBP30

1H-Benzimidazole, 2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-4-isoxazolyl)-1-[(2S)-2-(4-morpholinyl)propyl]-

SGC-CBP30 USP/EP/BP

(S)-4-(1-(2-(3-Chloro-4-methoxyphenethyl)-5-(3,5-dimethylisoxazol-4-yl)-1H-benzo[d]imidazol-1-yl)propan-2-yl)morpholine

inhibit,IL-17A,HAT,HATs,BRD,Histone Acetyltransferase,ankylosing,SGCCBP30,cells,epigenetic,spondylitis,anti-inflammatory,arthritis,SGC-CBP30,Epigenetic Reader Domain,SGC-CBP-30,Th17,psoriatic,SGC CBP30,Inhibitor

1613695-14-9

C28H33ClN4O3

Inhibitors